Sale disclosed
Fred Aslan
Chief Executive Officer
Common Stock
- Reported value
- $168.88K
- Reported price
- $7.1977 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Artiva Biotherapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $981.89K by 4 insiders.
Showing the first 6 of 17 trades on this page.
Chief Executive Officer
Common Stock
Chief Tech Operations Officer
Common Stock
$28,803,280 of common-equity purchase value after transaction-age decay across 180 days.
2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
COO, CLO, Compliance Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Tech Operations Officer
Common Stock
COO, CLO, Compliance Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Common Stock
SVP, Research and Development
Common Stock
Chief Tech Operations Officer
Common Stock
COO, CLO, Compliance Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Executive Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Executive Officer | Common StockSale10b5-1 | 23,463$7.20 / share | $168.88K | Oct 6Filed Oct 7 · 1d later | SEC filing |
| Chief Tech Operations Officer | Common StockSale | 10,340$6.84 / share | $70.7K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| COO, CLO, Compliance Officer | Common StockSale | 8,370$6.84 / share | $57.23K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chief Medical Officer | Common StockSale | 1,099$6.84 / share | $7.51K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chief Executive Officer | Common StockSale | 61,696$6.84 / share | $421.83K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chief Executive Officer | Common StockSale10b5-1 | 23,429$10.92 / share | $255.75K | Sep 8Filed Sep 9 · 1d later | SEC filing |
| Chief Tech Operations Officer | Common StockSale | 10,366$11.16 / share | $115.64K | Sep 3Filed Sep 4 · 1d later | SEC filing |
| COO, CLO, Compliance Officer | Common StockSale | 8,391$11.16 / share | $93.61K | Sep 3Filed Sep 4 · 1d later | SEC filing |
| Chief Medical Officer | Common StockSale | 1,100$11.16 / share | $12.27K | Sep 3Filed Sep 4 · 1d later | SEC filing |
| Chief Executive Officer | Common StockSale | 61,888$11.16 / share | $690.39K | Sep 3Filed Sep 4 · 1d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-1 | 8,222$12.01 / share | $98.74K | Aug 27Filed Aug 31 · 4d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-1 | 429$12.00 / share | $5.15K | Aug 18Filed Aug 19 · 1d later | SEC filing |
| SVP, Research and Development | Common StockSale | 3,095$9.01 / share | $27.88K | May 19Filed May 19 · 0d later | SEC filing |
| Chief Tech Operations Officer | Common StockSale | 7,002$9.01 / share | $63.07K | May 19Filed May 19 · 0d later | SEC filing |
| COO, CLO, Compliance Officer | Common StockSale | 8,790$9.01 / share | $79.18K | May 19Filed May 19 · 0d later | SEC filing |
| Chief Medical Officer | Common StockSale | 7,037$9.01 / share | $63.39K | May 19Filed May 19 · 0d later | SEC filing |
| Chief Executive Officer | Common StockSale | 27,116$9.01 / share | $244.25K | May 19Filed May 19 · 0d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.